Canada markets open in 3 hours 21 minutes

Protagonist Therapeutics, Inc. (PTGX)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
25.54-0.02 (-0.08%)
At close: 04:00PM EDT
25.60 +0.06 (+0.23%)
After hours: 05:19PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 1.50B
Enterprise Value 1.16B
Trailing P/E N/A
Forward P/E 14.18
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)24.16
Price/Book (mrq)4.45
Enterprise Value/Revenue 19.29
Enterprise Value/EBITDA -12.81

Trading Information

Stock Price History

Beta (5Y Monthly) 2.05
52-Week Change 33.02%
S&P500 52-Week Change 321.33%
52 Week High 333.34
52 Week Low 313.72
50-Day Moving Average 328.15
200-Day Moving Average 321.88

Share Statistics

Avg Vol (3 month) 3579.45k
Avg Vol (10 day) 3471.03k
Shares Outstanding 558.64M
Implied Shares Outstanding 658.64M
Float 840.77M
% Held by Insiders 11.69%
% Held by Institutions 199.92%
Shares Short (Apr 15, 2024) 43.52M
Short Ratio (Apr 15, 2024) 45.85
Short % of Float (Apr 15, 2024) 46.12%
Short % of Shares Outstanding (Apr 15, 2024) 46.05%
Shares Short (prior month Mar 15, 2024) 43.42M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin -131.59%
Operating Margin (ttm)38.41%

Management Effectiveness

Return on Assets (ttm)-19.32%
Return on Equity (ttm)-28.59%

Income Statement

Revenue (ttm)60M
Revenue Per Share (ttm)1.06
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -92.67M
Net Income Avi to Common (ttm)-78.95M
Diluted EPS (ttm)-1.39
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)341.62M
Total Cash Per Share (mrq)5.86
Total Debt (mrq)1.14M
Total Debt/Equity (mrq)0.34%
Current Ratio (mrq)16.71
Book Value Per Share (mrq)5.83

Cash Flow Statement

Operating Cash Flow (ttm)-70.24M
Levered Free Cash Flow (ttm)-43.31M